Zydus Cadila gets USFDA nod to market muscle spasms tablets
Posted by
www.biotecnika.org
The company has received final approval from the United States Food
and Drug Administration (USFDA) to market Baclofen tablets in the
strength of 5 mg, Zydus Cadila said in a statement. The product will
be manufactured at the group's formulations manufacturing facility at
Baddi, it added.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-to-market-muscle-spasms-tablets/articleshow/75218041.cms
Subscribe to:
Post Comments (Atom)
Post a Comment